Another potential target of wnt/β-catenin signaling in CRC, the histone lysine methyltransferase 2 A oncoprotein (KMT2A), has been identified by functional genomic screens as regulator of β-catenin transcriptional output [23]. Here, KMT2A is linked to colorectal carcinoma.